Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2B | P41595 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7093065 | 1.00 | HTR2B (0.42) | HTR2BALDH1A1HPGDBCL2L1HSD17B10 | |
| SCHEMBL18470041 | 0.86 | HTR2B (0.55) | HTR2B | |
| SCHEMBL10902401 | 0.81 | — | — | |
| SCHEMBL5674927 | 0.81 | — | — | |
| SCHEMBL723725 | 0.81 | — | — | |
| SCHEMBL7724707 | 0.77 | RXRA (0.50) | ALDH1A1HPGD | |
| SCHEMBL7723380 | 0.77 | RXRA (0.50) | ALDH1A1HPGD | |
| SCHEMBL25746548 | 0.75 | MAPT (0.55) | ALDH1A1HPGDBCL2L1HSD17B10POLB | |
| SCHEMBL25746558 | 0.75 | MAPT (0.55) | ALDH1A1HPGDBCL2L1HSD17B10POLB | |
| SCHEMBL4751169 | 0.74 | NPC1 (0.43) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8500260-B2 | Ink compositions incorporating substituted oxazoline compounds or substituted oxazoline derivatives | XEROX CORPORATION (US) | 2013-08-06 | — | — | US | disclosed |
| US-8500260-B2 | Ink compositions incorporating substituted oxazoline compounds or substituted oxazoline derivatives | XEROX CORPORATION (US) | 2013-08-06 | — | — | US | disclosed |
| US-8460447-B2 | Substituted oxazoline compounds or substituted oxazoline derivatives | XEROX CORPORATION (US) | 2013-06-11 | — | — | US | disclosed |
| US-8460447-B2 | Substituted oxazoline compounds or substituted oxazoline derivatives | XEROX CORPORATION (US) | 2013-06-11 | — | — | US | disclosed |
| US-20120274710-A1 | INK COMPOSITIONS INCORPORATING SUBSTITUTED OXAZOLINE COMPOUNDS OR SUBSTITUTED OXAZOLINE DERIVATIVES | XEROX CORPORATION (US) | 2012-11-01 | — | — | US | disclosed |
| US-20120272859-A1 | SUBSTITUTED OXAZOLINE COMPOUNDS OR SUBSTITUTED OXAZOLINE DERIVATIVES | XEROX CORPORATION (US) | 2012-11-01 | — | — | US | disclosed |
| US-20120272859-A1 | SUBSTITUTED OXAZOLINE COMPOUNDS OR SUBSTITUTED OXAZOLINE DERIVATIVES | XEROX CORPORATION (US) | 2012-11-01 | — | — | US | disclosed |
| US-20120274710-A1 | INK COMPOSITIONS INCORPORATING SUBSTITUTED OXAZOLINE COMPOUNDS OR SUBSTITUTED OXAZOLINE DERIVATIVES | XEROX CORPORATION (US) | 2012-11-01 | — | — | US | disclosed |
| US-6403623-B1 | ADMINISTERING 2-(2-SUBSTITUTED-PHENYL)-2-OXAZOLINES AND RELATED 5-MEMBERED HETEROCYCLES | UNUVERSITY OF NOTRE DAME DU LAC | 2002-06-11 | — | — | US | disclosed |
| US-6310058-B1 | N-HYDROXYAZEPIN-2-ONES SUBSTITUTED AT 3 POSITION WITH A GROUP CONTAINING A 2-PHENYLOXAZOLE OR 2-PHENYLOXAZOLINE GROUP FOR TREATING TUBERCULOSIS | UNIVERSITY OF NOTRE DAME DU LAC | 2001-10-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120272859-A1 | SUBSTITUTED OXAZOLINE COMPOUNDS OR SUBSTITUTED OXAZOLINE DERIVATIVES | CDK7, CDK17, ULK2 | HTR2B 1578/4885ALDH1A1 2566/4885HPGD 2568/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.